It is well recognized that intermittent fasting and time restricted feeding can improve health incl. treatment of metabolic syndrome, but there had not been many studies done on the mechanism behind the anticancer effect of time restricted feeding or intermittent fasting. The findings in this paper suggest that fasting from dawn to sunset can be an effective treatment for metabolic syndrome and prevention of cancer in humans.

The fasting-mimicking diet (FMD) is a plant-based, 5-day dietary intervention designed to emulate fasting benefits while minimizing negative side effects. Developed by Dr. Valter Longo and his team, recent clinical trials show FMD can lower biological age by 2.5 years, enhance insulin sensitivity and reduce liver fat, making it a promising strategy for improving healthspan and combating chronic diseases.

One of the problems when it comes to a person getting older is the progressive frailty that accompanies them later in life. Frailty from aging results in issues involving the failure of various physiological functions and systems, including but not limited to the development of

Elevated oxidative stress and mitochondrial dysfunction are key factors in biological aging. Glutathione (GSH), the body's most abundant intracellular antioxidant, plays a critical role in protecting mitochondria from oxidative damage. This double-blind randomized clinical trial explored the effects of GlyNAC supplementation—a combination of glycine and N-acetylcysteine, both GSH precursors—on older adults.